{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:21:13Z","timestamp":1790238073353,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1002\/rth2.12811","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:59:55Z","timestamp":1670565595000},"page":"e12811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Platelet caspase\u20101 and Bruton tyrosine kinase activation in patients with COVID\u201019 is associated with disease severity and reversed in vitro by ibrutinib"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6415-3941","authenticated-orcid":false,"given":"Livia","family":"Claude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1389-2306","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-9733","authenticated-orcid":false,"given":"Patricia","family":"Hermand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0892-0779","authenticated-orcid":false,"given":"Bassel","family":"Chahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-3093","authenticated-orcid":false,"given":"Pierre\u2010Marie","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-378X","authenticated-orcid":false,"given":"Marie","family":"de Bourayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-5829","authenticated-orcid":false,"given":"Yohann","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-4281","authenticated-orcid":false,"given":"Benoit","family":"Tressieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-4254","authenticated-orcid":false,"given":"Yves","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3251-1310","authenticated-orcid":false,"given":"Caroline","family":"Le Van Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8715-9836","authenticated-orcid":false,"given":"Marc","family":"Romana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3913-7664","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Baccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1002\/rth2.12811_bb0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"10223","key":"10.1002\/rth2.12811_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/rth2.12811_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID\u201019: interleukin\u20106 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1002\/rth2.12811_bb0025","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID\u201019","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1002\/rth2.12811_bb0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/09537104.2020.1754383","article-title":"Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study","volume":"31","author":"Liu","year":"2020","journal-title":"Platelets"},{"key":"10.1002\/rth2.12811_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2020.06.008","article-title":"Mechanisms involved in the development of thrombocytopenia in patients with COVID\u201019","volume":"193","author":"Zhang","year":"2020","journal-title":"Thromb Res"},{"issue":"18","key":"10.1002\/rth2.12811_bb0040","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China medical treatment expert group for COVID\u201019. Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1002\/rth2.12811_bb0045","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jth.14848","article-title":"Thrombocytopenia and its association with mortality in patients with COVID\u201019","volume":"18","author":"Yang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12811_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID\u201019) infections: a meta\u2010analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1002\/rth2.12811_bb0055","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID\u201019): a meta\u2010analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"10.1002\/rth2.12811_bb0060","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet\u2010monocyte aggregate formation trigger tissue factor expression in patients with severe COVID\u201019","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1002\/rth2.12811_bb0065","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID\u201019","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"issue":"23","key":"10.1002\/rth2.12811_bb0070","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID\u201019 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"issue":"18","key":"10.1002\/rth2.12811_bb0075","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2013-07-515536","article-title":"Influenza virus H1N1 activates platelets through Fc\u03b3RIIA signaling and thrombin generation","volume":"123","author":"Boilard","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1002\/rth2.12811_bb0080","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2018-09-873984","article-title":"Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3","volume":"133","author":"Campbell","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1002\/rth2.12811_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007625","article-title":"Dengue virus nonstructural protein 1 activates platelets via toll\u2010like receptor 4, leading to thrombocytopenia and hemorrhage","volume":"15","author":"Chao","year":"2019","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1002\/rth2.12811_bb0090","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1002\/rth2.12811_bb0095","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/s41467-019-10360-4","article-title":"Extracellular vesicles from CLEC2\u2010activated platelets enhance dengue virus\u2010induced lethality via CLEC5A\/TLR2","volume":"10","author":"Sung","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1002\/rth2.12811_bb0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1002\/rth2.12811_bb0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/187152810793937991","article-title":"Platelet toll\u2010like receptor expression: the link between \u00ab danger \u00bb ligands and inflammation","volume":"9","author":"Garraud","year":"2010","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"20","key":"10.1002\/rth2.12811_bb0110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0960-9822(98)70471-3","article-title":"A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen","volume":"8","author":"Quek","year":"1998","journal-title":"Curr Biol"},{"issue":"5","key":"10.1002\/rth2.12811_bb0115","first-page":"1663","article-title":"Rapid tyrosine phosphorylation and activation of Bruton's tyrosine\/Tec kinases in platelets induced by collagen binding or CD32 cross\u2010linking","volume":"95","author":"Oda","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1002\/rth2.12811_bb0120","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2006-01-011817","article-title":"Bruton tyrosine kinase is essential for botrocetin\/VWF\u2010induced signaling and GPIb\u2010dependent thrombus formation in vivo","volume":"108","author":"Liu","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1002\/rth2.12811_bb0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3324\/haematol.2019.218545","article-title":"Low\u2010dose Btk inhibitors selectively block platelet activation by CLEC\u20102","volume":"106","author":"Nicolson","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1002\/rth2.12811_bb0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2016.12.161","article-title":"The NLRP3 inflammasome and bruton's tyrosine kinase in platelets co\u2010regulate platelet activation, aggregation, and in vitro thrombus formation","volume":"483","author":"Murthy","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"10.1002\/rth2.12811_bb0135","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood-2013-05-504449","article-title":"Platelets mediate increased endothelium permeability in dengue through NLRP3\u2010inflammasome activation","volume":"122","author":"Hottz","year":"2013","journal-title":"Blood"},{"key":"10.1002\/rth2.12811_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajem.2020.12.023","article-title":"D\u2010Dimer as a potential biomarker for disease severity in COVID\u201019","volume":"40","author":"Ozen","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1002\/rth2.12811_bb0145","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID\u201019 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1002\/rth2.12811_bb0150","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/jnnp-2020-323586","article-title":"Characteristics of ischaemic stroke associated with COVID\u201019","volume":"91","author":"Beyrouti","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/rth2.12811_bb0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID\u201019","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12811_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID\u201019 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"10.1002\/rth2.12811_bb0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00003246-200204000-00005","article-title":"Time course of platelet counts in critically ill patients","volume":"30","author":"Akca","year":"2002","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1002\/rth2.12811_bb0170","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjh.16791","article-title":"More on COVID\u201019 coagulopathy in Caucasian patients","volume":"189","author":"Fogarty","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1002\/rth2.12811_bb0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2796.2010.02285.x","article-title":"Inflammation\u2010related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function","volume":"269","author":"Lanza","year":"2011","journal-title":"J Intern Med"},{"issue":"1","key":"10.1002\/rth2.12811_bb0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000512007","article-title":"The impact of COVID\u201019 disease on platelets and coagulation","volume":"88","author":"Wool","year":"2021","journal-title":"Pathobiology"},{"issue":"1","key":"10.1002\/rth2.12811_bb0185","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1038\/s41598-019-43275-7","article-title":"Platelet function in HIV plus dengue coinfection associates with reduced inflammation and milder dengue illness","volume":"9","author":"Hottz","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1002\/rth2.12811_bb0190","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/infdis\/jit260","article-title":"Highly active antiretroviral therapy alters inflammation linked to platelet cytokines in HIV\u20101\u2010infected patients","volume":"208","author":"Damien","year":"2013","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1002\/rth2.12811_bb0195","first-page":"191","article-title":"The role of platelet\u2010activating factor in chronic inflammation, immune activation, and comorbidities associated with HIV infection","volume":"17","author":"Kelesidis","year":"2015","journal-title":"AIDS Rev"},{"key":"10.1002\/rth2.12811_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106521","article-title":"Isofraxidin ameliorated influenza viral inflammation in rodents via inhibiting platelet aggregation","volume":"84","author":"Jin","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1002\/rth2.12811_bb0205","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201406-1031OC","article-title":"Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis","volume":"191","author":"L\u00ea","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1002\/rth2.12811_bb0210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS\u2010CoV\u20102 binds platelet ACE2 to enhance thrombosis in COVID\u201019","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1002\/rth2.12811_bb0215","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1002\/rth2.12811_bb0220","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14073","article-title":"NLRP3 inflammasome activation in platelets in response to sepsis","volume":"7","author":"Cornelius","year":"2019","journal-title":"Physiol Rep"},{"issue":"2","key":"10.1002\/rth2.12811_bb0225","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of toll\u2010like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"10.1002\/rth2.12811_bb0230","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID\u201019: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1002\/rth2.12811_bb0235","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41577-020-0353-y","article-title":"Author Correction: Pathological inflammation in patients with COVID\u201019: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1002\/rth2.12811_bb0240","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacbts.2020.04.006","article-title":"Precision medicine in COVID\u201019: IL\u20101\u03b2 a potential target","volume":"5","author":"Parisi","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1002\/rth2.12811_bb0245","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS\u2010CoV\u20102 infection and are associated with COVID\u201019 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"issue":"5","key":"10.1002\/rth2.12811_bb0250","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1182\/bloodadvances.2020003918","article-title":"Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID\u201019 severity","volume":"5","author":"Courjon","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1002\/rth2.12811_bb0255","doi-asserted-by":"crossref","first-page":"19839","DOI":"10.1038\/s41598-020-76836-2","article-title":"Similarities and differences between the \u00ab cytokine storms \u00bb in acute dengue and COVID\u201019","volume":"10","author":"Dayarathna","year":"2020","journal-title":"Sci Rep"},{"key":"10.1002\/rth2.12811_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198171","article-title":"IFN\u2010\u03b3 is an independent risk factor associated with mortality in patients with moderate and severe COVID\u201019 infection","volume":"289","author":"Gadotti","year":"2020","journal-title":"Virus Res"},{"issue":"8","key":"10.1002\/rth2.12811_bb0265","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2020008762","article-title":"Antibody\u2010induced procoagulant platelets in severe COVID\u201019 infection","volume":"137","author":"Althaus","year":"2021","journal-title":"Blood"},{"issue":"16","key":"10.1002\/rth2.12811_bb0270","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood.2021011871","article-title":"Aberrant glycosylation of anti\u2010SARS\u2010CoV\u20102 IgG is a pro\u2010thrombotic stimulus for platelets","volume":"138","author":"Bye","year":"2021","journal-title":"Blood"},{"issue":"21","key":"10.1002\/rth2.12811_bb0275","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK\u2010inhibitor ibrutinib may protect against pulmonary injury in COVID\u201019 infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"issue":"48","key":"10.1002\/rth2.12811_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID\u201019","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci Immunol"},{"issue":"26","key":"10.1002\/rth2.12811_bb0285","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2014-06-583294","article-title":"Ibrutinib treatment affects collagen and von Willebrand factor\u2010dependent platelet functions","volume":"124","author":"Levade","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1002\/rth2.12811_bb0290","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/leu.2014.247","article-title":"Ibrutinib inhibits collagen\u2010mediated but not ADP\u2010mediated platelet aggregation","volume":"29","author":"Kamel","year":"2015","journal-title":"Leukemia"},{"issue":"11","key":"10.1002\/rth2.12811_bb0295","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/ATVBAHA.115.306130","article-title":"Ibrutinib inhibits platelet integrin \u03b1IIb\u03b23 outside\u2010in signaling and thrombus stability but not adhesion to collagen","volume":"35","author":"Bye","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1002\/rth2.12811_bb0300","doi-asserted-by":"crossref","first-page":"C373","DOI":"10.1152\/ajpcell.00325.2015","article-title":"Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI\u2010mediated platelet function","volume":"310","author":"Rigg","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"10.1002\/rth2.12811_bb0305","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood-2009-02-205328","article-title":"The new tyrosine\u2010kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo","volume":"114","author":"Gratacap","year":"2009","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12811","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12811","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922024281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922024281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:25:08Z","timestamp":1762863908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922024281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2475037922024281"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12811","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet caspase\u20101 and Bruton tyrosine kinase activation in patients with COVID\u201019 is associated with disease severity and reversed in vitro by ibrutinib","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis (ISTH)","name":"copyright","label":"Copyright"}],"article-number":"e12811"}}